Rocket Pharmaceuticals (RCKT)
3.30
-0.10 (2.94%)
Upcoming Events
Latest Headlines
Form S-8 ROCKET PHARMACEUTICALS,
July 14, 2026 4:06 PM - SEC Filing
Form 3 ROCKET PHARMACEUTICALS, For: Jul 08 Filed by: Manhede Joseph
July 8, 2026 7:05 PM - SEC Filing
Form 144 ROCKET PHARMACEUTICALS, Filed by: Malik Fady Ibraham
July 7, 2026 3:13 PM - SEC Filing
Form 4 ROCKET PHARMACEUTICALS, For: Jun 18 Filed by: WONG RODERICK
July 6, 2026 8:00 PM - SEC Filing
Form 4 ROCKET PHARMACEUTICALS, For: Jun 18 Filed by: Dolsten Mikael
July 6, 2026 8:00 PM - SEC Filing
Form 4 ROCKET PHARMACEUTICALS, For: Jun 18 Filed by: Fong Peter
July 6, 2026 8:00 PM - SEC Filing
Form 4 ROCKET PHARMACEUTICALS, For: Jun 18 Filed by: Malik Fady Ibraham
July 6, 2026 8:00 PM - SEC Filing
Form 4 ROCKET PHARMACEUTICALS, For: Jun 18 Filed by: SOUTHWELL DAVID P
July 6, 2026 8:00 PM - SEC Filing
Form 4 ROCKET PHARMACEUTICALS, For: Jun 18 Filed by: BOESS CARSTEN
July 6, 2026 8:00 PM - SEC Filing
Form 8-K ROCKET PHARMACEUTICALS, For: Jun 24
June 30, 2026 5:16 PM - SEC Filing
Form 8-K ROCKET PHARMACEUTICALS, For: Jun 10
June 12, 2026 7:11 AM - SEC Filing
Rocket Pharmaceuticals completes $180 million priority review voucher sale
June 12, 2026 7:01 AM - StreetInsider
Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 Million
June 12, 2026 7:00 AM - BizWire
Form SC TO-I/A ROCKET PHARMACEUTICALS, Filed by: ROCKET PHARMACEUTICALS, INC.
May 28, 2026 5:51 PM - SEC Filing
Form 4 ROCKET PHARMACEUTICALS, For: May 26 Filed by: Militello John
May 28, 2026 5:13 PM - SEC Filing
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
May 28, 2026 7:00 AM - BizWire
Form 4 ROCKET PHARMACEUTICALS, For: May 21 Filed by: Shah Gaurav
May 26, 2026 7:47 PM - SEC Filing
Form 4 ROCKET PHARMACEUTICALS, For: May 19 Filed by: Shah Gaurav
May 21, 2026 4:07 PM - SEC Filing
Form 4 ROCKET PHARMACEUTICALS, For: May 19 Filed by: Wilson Martin
May 21, 2026 4:07 PM - SEC Filing
Form 4 ROCKET PHARMACEUTICALS, For: May 19 Filed by: Militello John
May 21, 2026 4:07 PM - SEC Filing
Form 144 ROCKET PHARMACEUTICALS, Filed by: Shah Gaurav
May 21, 2026 3:41 PM - SEC Filing
Form 8-K ROCKET PHARMACEUTICALS, For: May 20
May 21, 2026 6:04 AM - SEC Filing
Form 144 ROCKET PHARMACEUTICALS, Filed by: Shah Gaurav
May 19, 2026 3:39 PM - SEC Filing
Form 144 ROCKET PHARMACEUTICALS, Filed by: Militello John
May 19, 2026 3:34 PM - SEC Filing
Form 144 ROCKET PHARMACEUTICALS, Filed by: Wilson Martin
May 19, 2026 3:20 PM - SEC Filing
Form 4 ROCKET PHARMACEUTICALS, For: May 13 Filed by: Wilson Martin
May 14, 2026 4:23 PM - SEC Filing
Form 4 ROCKET PHARMACEUTICALS, For: May 13 Filed by: Shah Gaurav
May 14, 2026 4:20 PM - SEC Filing
Form 4 ROCKET PHARMACEUTICALS, For: May 13 Filed by: Militello John
May 14, 2026 4:17 PM - SEC Filing
Form 144 ROCKET PHARMACEUTICALS, Filed by: Wilson Martin
May 13, 2026 3:16 PM - SEC Filing
Form 144 ROCKET PHARMACEUTICALS, Filed by: Shah Gaurav
May 13, 2026 3:13 PM - SEC Filing
Form 144 ROCKET PHARMACEUTICALS, Filed by: Militello John
May 13, 2026 3:10 PM - SEC Filing
Form 4 ROCKET PHARMACEUTICALS, For: May 07 Filed by: Chaudhuri Sarbani
May 11, 2026 7:48 PM - SEC Filing
Rocket Pharmaceuticals (RCKT) PT Raised to $15 at Cantor Fitzgerald
May 8, 2026 8:07 AM - StreetInsider
Rocket Pharmaceuticals (RCKT) Misses Q1 EPS by 2c
May 7, 2026 5:54 PM - StreetInsider
Form 8-K ROCKET PHARMACEUTICALS, For: May 07
May 7, 2026 4:47 PM - SEC Filing
Form 10-Q ROCKET PHARMACEUTICALS, For: Mar 31
May 7, 2026 4:08 PM - SEC Filing
Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress
May 7, 2026 4:00 PM - BizWire
Form 144 ROCKET PHARMACEUTICALS, Filed by: Chaudhuri Sarbani
May 7, 2026 3:15 PM - SEC Filing
Rocket Pharmaceuticals (RCKT) PT Raised to $12 at Leerink Partners
April 28, 2026 9:20 AM - StreetInsider
Form 8-K ROCKET PHARMACEUTICALS, For: Apr 26
April 28, 2026 7:35 AM - SEC Filing
Rocket Pharmaceuticals sells priority review voucher for $180 million
April 28, 2026 7:00 AM - StreetInsider
Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher
April 28, 2026 7:00 AM - BizWire
Form SC TO-I ROCKET PHARMACEUTICALS, Filed by: ROCKET PHARMACEUTICALS, INC.
April 27, 2026 9:43 AM - SEC Filing
Full Article List
